<DOC>
	<DOCNO>NCT01910246</DOCNO>
	<brief_summary>It show asymptomatic obese adolescent demonstrate abnormal regional myocardial contraction , preserve global cardiac function . Metformin show decrease cardiovascular mortality patient type 2 diabetes insulin resistance , mechanism cardiovascular protection unknown . The purpose study evaluate reversibility subclinical cardiovascular abnormality obese adolescent insulin resistance six-month course Metformin . The investigator hypothesize beneficial effect Metformin progressive sustain six month therapy .</brief_summary>
	<brief_title>Cardiovascular Effects Metformin Obesity</brief_title>
	<detailed_description />
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Adolescents 12 17 year old clinical care UCSF WATCH clinic Body mass index &gt; 95th percentile age gender accord Centers Disease Control Prevention 2000 growth chart United States Insulin resistant 6 month healthy diet exercise Able understand assent form Patients known cardiac disease Patients contraindication metformin list : Renal disease renal ( serum creatinine level ≥1.5 mg/dL male , ≥1.4 mg/dL female ; Known hypersensitivity Metformin ; Acute chronic metabolic acidosis ; Patients contraindication MRI include : Cardiac pacemaker ; Claustrophobia ; Metallic foreign body eye , Aneurysm clip brain Pregnancy ; Patients could stay still 30 minute within MRI scanner due reason besides claustrophobia</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Metformin</keyword>
	<keyword>Insulin Resistance</keyword>
	<keyword>Cardiac Function</keyword>
</DOC>